🇺🇸 FDA
Pipeline program

Low Molecular Weight Heparin (LMWH)

SPON1037-11

Phase 2 small_molecule terminated

Quick answer

Low Molecular Weight Heparin (LMWH) for Cancer is a Phase 2 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
Cardiff Oncology
Indication
Cancer
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials